Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)

CNY 12.69

(0.0%)

Total Assets Summary of Chongqing Pharscin Pharmaceutical Co., Ltd.

  • Chongqing Pharscin Pharmaceutical Co., Ltd.'s latest annual total assets in 2023 was 1.85 Billion CNY , down -0.81% from previous year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd.'s latest quarterly total assets in 2024 Q3 was 1.91 Billion CNY , up 1.91% from previous quarter.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. reported annual total assets of 1.86 Billion CNY in 2022, up 5.37% from previous year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. reported annual total assets of 1.77 Billion CNY in 2021, up 2.91% from previous year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. reported quarterly total assets of 1.89 Billion CNY for 2024 Q1, up 2.09% from previous quarter.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. reported quarterly total assets of 1.87 Billion CNY for 2024 Q2, down -0.76% from previous quarter.

Annual Total Assets Chart of Chongqing Pharscin Pharmaceutical Co., Ltd. (2023 - 2013)

Historical Annual Total Assets of Chongqing Pharscin Pharmaceutical Co., Ltd. (2023 - 2013)

Year Total Assets Total Assets Growth
2023 1.85 Billion CNY -0.81%
2022 1.86 Billion CNY 5.37%
2021 1.77 Billion CNY 2.91%
2020 1.72 Billion CNY 5.13%
2019 1.63 Billion CNY 49.73%
2018 1.09 Billion CNY 23.55%
2017 885.14 Million CNY 35.69%
2016 652.32 Million CNY 20.96%
2015 539.29 Million CNY 0.35%
2014 537.39 Million CNY 29.38%
2013 415.35 Million CNY 0.0%

Peer Total Assets Comparison of Chongqing Pharscin Pharmaceutical Co., Ltd.

Name Total Assets Total Assets Difference
Shenzhen Neptunus Bioengineering Co., Ltd. 32.3 Billion CNY 94.269%
Anhui Fengyuan Pharmaceutical Co., Ltd. 4.39 Billion CNY 57.838%
Dong-E-E-Jiao Co.,Ltd. 13.3 Billion CNY 86.086%
Livzon Pharmaceutical Group Inc. 25.04 Billion CNY 92.607%
Hainan Haiyao Co., Ltd. 7.36 Billion CNY 74.867%
Tus-Pharmaceutical Group Co., Ltd. 1.15 Billion CNY -60.839%
Jilin Aodong Pharmaceutical Group Co., Ltd. 32.26 Billion CNY 94.262%
Changchun High-Tech Industries (Group) Inc. 30.74 Billion CNY 93.978%
Apeloa Pharmaceutical Co.,Ltd 12.76 Billion CNY 85.499%
PKU HealthCare Corp.,Ltd. 2.43 Billion CNY 24.067%
Chengdu Huasun Technology Group Inc., Ltd. 2.13 Billion CNY 13.219%
Dezhan Healthcare Company Limited 5.37 Billion CNY 65.577%
Jinling Pharmaceutical Company Limited 4.55 Billion CNY 59.313%
Jiuzhitang Co., Ltd. 5.32 Billion CNY 65.262%
Huapont Life Sciences Co., Ltd. 30.72 Billion CNY 93.975%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 7.98 Billion CNY 76.818%
Shandong Wohua Pharmaceutical Co., Ltd. 1.14 Billion CNY -61.741%
Hengkang Medical Group Co., Ltd. 6.08 Billion CNY 69.549%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 6.45 Billion CNY 71.333%
Qianjiang Yongan Pharmaceutical Co., Ltd. 2.34 Billion CNY 21.119%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 19.2 Billion CNY 90.359%
Jinhe Biotechnology CO., LTD. 5.45 Billion CNY 66.052%
Teyi Pharmaceutical Group Co.,Ltd 2.51 Billion CNY 26.314%
Kunming Longjin Pharmaceutical Co., Ltd. 631.63 Million CNY -193.121%
Beijing Aosaikang Pharmaceutical Co., Ltd. 3.52 Billion CNY 47.46%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 8.52 Billion CNY 78.294%
Anhui Huangshan Capsule Co., Ltd. 1.1 Billion CNY -67.843%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 2.12 Billion CNY 12.874%
Zhuhai Rundu Pharmaceutical Co., Ltd. 2.22 Billion CNY 16.892%
Huaren Pharmaceutical Co., Ltd. 5.16 Billion CNY 64.159%
Tianjin Ringpu Bio-Technology Co.,Ltd. 6.59 Billion CNY 71.93%
Shanxi Zhendong Pharmaceutical Co.,Ltd 6.18 Billion CNY 70.044%
Fuan Pharmaceutical (Group) Co., Ltd. 5.97 Billion CNY 69.018%
Hybio Pharmaceutical Co., Ltd. 3.27 Billion CNY 43.505%
Baotou Dongbao Bio-Tech Co.,Ltd 2.74 Billion CNY 32.478%
Hunan Er-Kang Pharmaceutical Co., Ltd 5.47 Billion CNY 66.209%
Changjiang Pharmaceutical Group Co., Ltd. 3.44 Billion CNY 46.269%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 5.26 Billion CNY 64.805%
Fujian Cosunter Pharmaceutical Co., Ltd. 1.61 Billion CNY -14.678%
Beijing Science Sun Pharmaceutical Co., Ltd. 3.62 Billion CNY 48.886%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 930.4 Million CNY -98.994%
Hainan Poly Pharm. Co., Ltd 6.28 Billion CNY 70.55%
Jiangxi Synergy Pharmaceutical Co., Ltd. 3.22 Billion CNY 42.527%
Wuhan Hiteck Biological Pharma Co.,Ltd 2.97 Billion CNY 37.688%
Shandong Xinhua Pharmaceutical Company Limited 8.35 Billion CNY 77.838%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 6.33 Billion CNY 70.789%
PharmaBlock Sciences (Nanjing), Inc. 5.1 Billion CNY 63.726%
Jinghua Pharmaceutical Group Co., Ltd. 3.18 Billion CNY 41.87%
Zhejiang Hisoar Pharmaceutical Co., Ltd. 7.52 Billion CNY 75.38%
Betta Pharmaceuticals Co., Ltd. 9.14 Billion CNY 79.759%
Tibet AIM Pharm. Inc. 927.74 Million CNY -99.565%
Shenzhen Kangtai Biological Products Co., Ltd. 15.08 Billion CNY 87.727%
Shandong Shanda Wit Science and Technology Co., Ltd. 5.19 Billion CNY 64.383%
Pacific Shuanglin Bio-pharmacy Co., LTD 8.63 Billion CNY 78.547%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 3.01 Billion CNY 38.693%
Xiamen Kingdomway Group Company 5.35 Billion CNY 65.415%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 1.43 Billion CNY -29.194%
Walvax Biotechnology Co., Ltd. 15.58 Billion CNY 88.123%
Sunflower Pharmaceutical Group Co.,Ltd 6.88 Billion CNY 73.097%
Harbin Gloria Pharmaceuticals Co., Ltd 3.15 Billion CNY 41.269%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 40.14 Billion CNY 95.388%
Hunan Hansen Pharmaceutical Co., Ltd. 2.33 Billion CNY 20.759%
Changzhou Qianhong Biopharma CO.,LTD 2.76 Billion CNY 33.066%
Shenzhen Weiguang Biological Products Co., Ltd. 2.87 Billion CNY 35.641%
Honz Pharmaceutical Co., Ltd. 2.16 Billion CNY 14.507%
Northeast Pharmaceutical Group Co., Ltd. 15.27 Billion CNY 87.878%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 4.52 Billion CNY 59.042%
Guizhou Xinbang Pharmaceutical Co., Ltd. 9.24 Billion CNY 79.973%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 5.78 Billion CNY 67.971%
Zhejiang Yatai Pharmaceutical Co., Ltd. 1.42 Billion CNY -29.529%
Zhejiang NHU Company Ltd. 39.15 Billion CNY 95.272%
ApicHope Pharmaceutical Co., Ltd 4.4 Billion CNY 57.972%
Shanghai Kaibao Pharmaceutical CO.,Ltd 4.57 Billion CNY 59.572%
Beijing SL Pharmaceutical Co., Ltd. 6.27 Billion CNY 70.508%
Yunnan Baiyao Group Co.,Ltd 53.78 Billion CNY 96.558%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 1.33 Billion CNY -38.514%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 1.54 Billion CNY -20.013%
Guangdong Lifestrong Pharmacy Co., Ltd. 855.53 Million CNY -116.409%
Huadong Medicine Co., Ltd 33.5 Billion CNY 94.475%
Jiangsu Nhwa Pharmaceutical Co., LTD 7.32 Billion CNY 74.735%
Harbin Medisan Pharmaceutical Co., Ltd. 3.44 Billion CNY 46.225%
LanZhou Foci Pharmaceutical Co.,Ltd. 2.52 Billion CNY 26.765%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 11.83 Billion CNY 84.356%
Beijing Beilu Pharmaceutical Co., Ltd 2.81 Billion CNY 34.332%
Nanjing Hicin Pharmaceutical Co., Ltd. 1.41 Billion CNY -30.485%
Renhe Pharmacy Co., Ltd. 7.44 Billion CNY 75.131%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 6.99 Billion CNY 73.524%
Luoxin Pharmaceuticals Group Stock Co., Ltd. 5.11 Billion CNY 63.82%
Guizhou Bailing Group Pharmaceutical Co., Ltd. 7.34 Billion CNY 74.807%